Objectives: The Centers for Disease Control and Prevention shifted the focus of surveillance paradigm for adult patients receiving mechanical ventilation, moving from the current standard of ventilator-associated pneumonia to broader complications. The surveillance definitions were designed to enable objective measures and efficient processes, so as to facilitate quality improvement initiatives and enhance standardized benchmark comparisons. We evaluated the surveillance definitions in term of their ability to predict clinical outcomes and ease of surveillance in a PICU. Design: Retrospective cohort study. Setting: A PICU at a university-affiliated children's hospital. Patients: Eight hundred thirty-six patients receiving mechanical ventilation over 1-year period. Interventions: None. Measurements and Main Results: We applied the definition for ventilator-associated condition (i.e., a sustained increase in ventilator setting after a period of stable or decreasing support) to our database. Of total 606 patients, 14.5% had ventilator-associated condition (20.9/1,000 ventilator days) and 8.1% had an infectionrelated ventilator-associated condition (12.9/1,000 ventilator days). The patients with infection-related ventilator-associated condition were classified into probable pneumonia (55%), possible pneumonia (28.6%), and undetermined infection (16.3%). A large portion of patients with ventilator-associated condition (44%) had other noninfectious etiologies (e.g., atelectasis, pulmonary edema, and shock). Patients who developed ventilator-associated condition had significantly longer ventilatory, ICU, and hospital days compared with those who did not. The ventilator-associated condition group had increased hospital mortality compared with the non-ventilatorassociated condition group (19.3% vs 6.9%; p = 0.0007). Multivariate regression analysis identified ventilator-associated condition as one of the predictors of hospital mortality with an adjusted odds ratio of 2.14 (95% CI, 1.03-4.42). Risk factors for developing a ventilator-associated condition included immunocompromised status (odds ratio, 2.90; 95% CI, 1.57-5.33), tracheostomy dependence (odds ratio, 2.78; 95% CI, 1.40-5.51), and chronic respiratory disease (odds ratio, 1.85; 95% CI, 1.03-3.3). Conclusions: The definitions for the various ventilator-associated conditions are good predictors of outcomes in children and adults and are amenable to automated surveillance. Based on the study findings, we suggest consideration for shifting the focus of surveillance for ventilator-associated events from only pneumonia to a broader range of complications. (Crit Care Med 2015; 43:2446-2451 
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The Centers for Disease Control and Prevention's New Definitions for Complications of Mechanical Ventilation Shift the Focus of Quality Surveillance and Predict Clinical Outcomes in a PICU
Siriporn Phongjitsiri, MD; Jorge Coss-Bu, MD; Curtis Kennedy, MD, PhD; Jaime Silva, MD; Jeffrey Starke, MD; Jeanine Graf, MD; Satid Thammasitboon, MD, MHPE T he rate of ventilator-associated pneumonia (VAP) commonly is used as a quality indicator for patients receiving mechanical ventilation. A concern is that reported rates are highly variable (0.1-21.6 per 1,000 ventilator days), depending on the personnel who collect and interpret the clinical and laboratory data and the intensity of the surveillance (1) (2) (3) . This variability likely is due, in part, to problematic definitions of VAP. The difficulties of accurately diagnosing VAP create challenges in determining the effectiveness of prevention strategies. The Centers for Disease Control and Prevention (CDC) shifted the focus of surveillance for adult patients receiving mechanical ventilation from VAP to a broader range of complications (4) . These new surveillance definitions were designed to be more objective and to render the data easier to collect and verify. The terms include ventilator-associated condition (VAC) and infection-related, ventilator-associated complication (IVAC) ( Table 1 ) (5) (6) (7) .
VAC is defined as a sustained period of worsening oxygenation that immediately follows a baseline period of stability or improvement on the ventilator. Subjective measures such as radiographic interpretations are not included in the criteria. The new definitions officially replaced CDC's traditional VAP definitions for adults in January 2013. In one study comparing VAC versus VAP surveillance, both VAC and VAP predicted prolonged mechanical ventilation and stay in an ICU, but only VAC was associated with increased rates of hospital mortality (8) .
Shifting the focus of surveillance from pneumonia to all ventilator-associated complications could enhance efficiency in identifying patients with potentially poor outcomes, simplify the surveillance process, and minimize the inconsistency that subjective VAP surveillance definitions permit (9) .
Studies in adults demonstrated that the VAC assessment was faster, more objective, and a superior predictor of outcomes. However, this approach has not yet been applied systematically to infants and children. Although the CDC has proposed this approach in pediatrics, there is, to date, no clear consensus on how these new definitions should be used in pediatrics. It is prudent to evaluate whether these definitions are applicable and beneficial for children. We conducted a retrospective study using an automated data recording and retrieval system to evaluate the CDC's new surveillance definitions for their ability to predict clinical outcomes in a PICU.
MATERIALS AND METHODS
We conducted a retrospective review of electronic medical records at Texas Children's Hospital, Houston, TX. The PICU is a 31-bed, combined medical and surgical unit. We enrolled all patients admitted to the PICU between October 1, 2012, and September 30, 2013, who were mechanically ventilated for more than 48 hours. Patients who met the inclusion criteria more than once due to multiple admissions to the ICU or intubations were regarded as unique patients. If the patients were reintubated within 24 hours of extubation, the total time of mechanical ventilation was considered continuous. Patients requiring progressive increases in the Fio 2 or positive endexpiratory pressure (PEEP) from intubation without subsequent stabilization on conventional mechanical ventilation or patients who died within 3 days of intubation were excluded. Patients receiving extracorporeal membrane oxygenation, high-frequency oscillatory ventilation (HFOV), and noninvasive, positive-pressure ventilation were also excluded, as the approaches to setting and adjusting the ventilators for these patients vastly differed from how we managed conventional mechanical ventilation. There is no practical approach to converting HFOV settings to equate PEEP changes.
Data Screening and Classification
In order to automate VAC screening, we developed and implemented a module for our locally developed clinical decision support system. The system is a collection of open-source software tools (i.e., screen scraping, text parsing, data import, module execution, webpage output, and form submission and e-mail) that automate the extracting of data from our electronic medical record and the processing of data into useful outputs. Our VAC module identified patients who met the VAC criteria (i.e., sustained increases in ventilator PEEP or Fio 2 , following a sustained period of stability or improvement). One of the investigators (S.P.) then reviewed all patient records to determine that no VAC cases were missed by the automated VAC screening. All patients with VAC were then assessed for the possibility that they had IVAC (i.e., probable, possible pneumonia, or undetermined infection). The remaining patients with VAC were reviewed to determine possible etiologies other than IVAC. Approval for the study was provided by the local institutional review board, and a waiver of consent was approved.
Data Collection
Patient characteristics collected were age, sex, body weight, Pediatric Logistic Organ Dysfunction (PELOD) score, Pediatric Index of Mortality (PIM) 2 score on ICU admission, comorbidities (e.g., underlying chronic respiratory diseases, subglottic or tracheal stenosis, complex medical conditions, immune status, tracheostomy dependence, and surgical problems), microbiology results, and radiographic findings. Clinical outcomes collected included duration of mechanical ventilation, length of stay (LOS) in PICU, hospital LOS, and ICU mortality.
Data Analysis
Baseline characteristics and clinical outcomes were compared between patients who had and who did not have VAC. Sex, comorbidities, and ICU mortality were described as counts and percentages and compared using the chi-square test and Fisher exact test. Age, body weight, PELOD, PIM 2 score, ventilator days, and ICU and hospital LOS were described as mean, median, sd, and interquartile range. Comparisons between groups were performed by t test for mean and Wilcoxon ranksum test for median. The incidences were reported as events per 1,000 ventilator days. We performed logistic regression analyses to determine associations between VAC along with other covariates and hospital mortality. Candidate variables with p up to 0.10 by univariate analysis, as well as other key clinical variables, were selected for inclusion in the multivariate model. A multivariate logistic regression model was used to determine the association between VAC as an independent variable and hospital mortality as a dependent variable. The statistical package SAS version 9.3 (SAS Institute, Cary, NC) was used for data analyses.
RESULTS
During the study period, 836 patients received mechanical ventilation for a total of 4,106 ventilator days. Of these, 631 patients were ventilated for more than 48 hours. Of the 631, 25 were excluded: three received high-frequency oscillatory ventilation and 22 experienced progressive respiratory deterioration resulting in death without stabilization of Fio 2 or PEEP. The remaining 606 patients' records (3,787 ventilator days) were reviewed and analyzed. Baseline patient characteristics are shown in Table 2 . There were 88 events that met the VAC definition (20.9 per 1,000 ventilator days). The median (interquartile rage) time-to-event was 10 days (4, 19.5). More than half of these VACs, 49 of 88 (55.7%), were classified as IVAC (12.9/1,000 ventilator days). The patients with IVAC were classified into probable pneumonia (7.1/1,000 ventilator days), possible pneumonia (3.7/1,000 ventilator days), and undetermined infection (2.1/1,000 ventilator days).
The patients in the VAC group had significantly higher PIM 2 score and had a history of chronic respiratory disease, immunocompromised status, tracheostomy dependence, and surgical procedure more frequently compared with those in the non-VAC group. No significant differences were noted between VAC and non-VAC patients with regard to age, sex, body weight, PELOD score, or other comorbidities (Table 2) . Comparing clinical outcomes, the patients with VAC had significantly longer durations of mechanical ventilation, ICU stay, and hospital stay ( Table 3) . The ICU mortality rates were 19.3% for the patients with VAC compared with 6.9% in patients without VAC (p = 0.0007). On multivariate logistic regression analysis, VAC was an independent predictor of mortality (odds ratio [OR], 2.14; 95% CI, 1.03-4.42) as were other risk factors: immunocompromised status, higher PELOD, and PIM 2 scores ( Table 4 ). The independent risks for VAC included a history of immunocompromised status (OR, 2.90; 95% CI, 1.57-5.33), tracheostomy dependence (OR, 2.78; 95% CI, 1.40-5.51), and chronic respiratory disease (OR, 1.85; 95% CI, 1.03-3.3). Comparing clinical outcomes of patients within the VAC group (IVAC vs non-IVAC), patients who had IVAC had significantly longer durations of ICU stay, hospital stay, and mechanical ventilation, and higher ICU mortality ( Table 5 ). There were no significant differences in duration of ICU stay and hospital stay, mechanical ventilation, and ICU mortality in patients who had IVAC compared with patients who had VAC from other causes ( Table 6 ).
The operational definition of VAC simplifies the surveillance process and allows for an automated screening via electronic medical record retrieval. In the current study, we were able to automatically identify events meeting definition criteria for VAC by designing a module to query our decision support database. With a single query that executed requested ventilator parameters, a span of 12 months of electronic PICU database (i.e., 606 patients with 3,787 ventilator days) could be screened for VAC. Our VAC module yielded sensitivity of 84.1% and specificity of 86.4% using the investigator's manual review as a reference standard. The false-positive and false-negative results were due to the transient technical failure within the clinical decision support system. Some VAC occurrences were missed during the lack of automated surveillance. Those cases were detected when we reviewed the database manually.
One of the study investigators (S.P.) reviewed the 88 events of VAC to determine possible etiologies responsible for respiratory deteriorations based on respiratory cultures, antibiotic therapy, diuretic prescriptions, chest radiography interpretations, and daily progress notes (Fig. 1) . The 39 non-IVAC events were attributed to as follows: 18 atelectasis (46%); five pulmonary edema (12.8%), four sepsis (10.3%), and one (2.6%) each to acute respiratory distress syndrome (ARDS), pulmonary hemorrhage, abdominal distention, pneumothorax, upper airway edema, and pericardial effusion. There were no apparent explanations for the remaining 14 events based on available information.
Of the 49 IVAC cases, 29 (59.2%) had positive cultures for bacterial pathogens from blind mini bronchoalveolarlavage samples, five cases were positive for viruses, and two cases were positive for both bacterial and viral pathogens. The organisms included Pseudomonas aeruginosa (37.9%), Haemophilus influenza (17.2%), Stenotrophomonas maltophilia (10.3%), Klebsiella pneumonia (6.9%), methicillin-susceptible Staphylococcus aureus (10.3%), and methicillin-resistant S. aureus (6.9%). Forty-three of the IVAC cases had radiographic findings reported as inconclusive or possible coexistence of two etiologies (e.g., atelectasis vs pneumonia).
DISCUSSION
To our knowledge, this is the first study of an application of the CDC's new surveillance definitions to a pediatric population. Furthermore, we studied the entire population of mechanically ventilated patients in a single PICU over a continuous interval rather than a random sampling of a population. The ventilatorassociated events algorithm provided operational definitions that were easily adapted for automated surveillance within our locally developed database system. Both VAC and IVAC were associated with increased mortality and longer durations of mechanical ventilation, ICU stay, and hospital stay. In two studies of adult patients, VAC was shown to correlate with clinical outcomes, including longer duration of stay in ICU and of mechanical ventilation, greater consumption of broadspectrum antibiotics, and significant morbidity and mortality (9, 10) . In another study, VAC was associated with greater consumption of broad-spectrum antibiotics but not with longer hospital stays or greater rates of ICU mortality (11) .
The proposed definition for VAC is purposefully broadened to capture processes such as atelectasis, ARDS, and pulmonary edema, in addition to pneumonia. Although pneumonia was an important contributor, 47% of the VACs were due to noninfectious causes (Fig. 1) . These findings were consistent with the previous study in adult patients, in which VACs were most often caused by volume overload and infections, but not necessarily pneumonia (12) . The IVAC subgroup also includes a broad spectrum of events that are caused by pulmonary infections, extrapulmonary infections, and noninfectious processes. Our results showed no significant differences in duration of ICU stay or hospital stay, mechanical ventilation, and ICU mortality in patients who had IVAC compared with patients who had other complications of VAC, suggesting that noninfectious complications of mechanical ventilation may be just as important as infectious etiologies.
Variability in interpretation of radiographic findings, subjectivity of some clinical criteria, and variability of specimen collection and culturing practices affect VAP case finding among institutions. Whereas 41 of 49 IVAC patients were classified as having pneumonia (probable or possible) in this study, only nine patients were previously diagnosed with VAP by traditional infection control surveillance methods in the same 1-year period. A prospective study in adult patients showed similar result with only 32% concordance between the two VAP surveillance methods (12) . This discrepancy does not necessarily reflect an error or poor concordance of pneumonia diagnoses but demonstrates the two fundamentally different approaches in identification of VAP. Theoretically, the group of nine previously documented VAP cases should have been a subset of IVAC cases, but we actually found only five of these patients who also met criteria for IVAC (four probable and The definitions for IVAC and its subcategories may appear somewhat arbitrary. The primary determinant of IVAC is the need for continuation of antibiotics for more than 4 days, justified by clinical judgment of a clinician responsible for patient care. These definitions are used to standardize documentation of VAC events that likely relate to infection and are not definitions for diagnosing pneumonia. Thus, this new surveillance system uses the terms "probable" and "possible" pneumonia and not "definitive" pneumonia. Their determination relies primarily on objective respiratory sample cultures and other microbiologic techniques and not on the commonly equivocal chest radiographic findings. According to our review of all IVAC cases, the majority (87.8%) had radiographic findings that were inconclusive or reported as possible coexistence of two etiologies (e.g., atelectasis vs pneumonia). Removing radiologic criteria from the surveillance definition for IVAC likely will have little impact on accuracy but could improve objectivity and reproducibility.
Limitations of our study include its retrospective nature, the inaugural use of our specific surveillance tool, and lack of comparison studies in pediatrics. Determining clinical explanations, rather than IVAC, for VAC was particularly challenging, as some clinical data were not documented adequately. The reviewers attempted to identify any possible causes based on available information in medical records. We chose to be inclusive and reported all possibilities, rather than attempting to distinguish the primary causes. Although comparisons of antimicrobial usage among varieties of VAC could provide meaningful clinical information, the format of our database was not conducive for chart reviews of a large database. Our institution-specific surveillance tool (i.e., VAC module) may not be widely applicable to other institutions. It is also important to emphasize that the associations identified in this study cannot be assumed as causations.
Ventilator-associated event surveillance is a promising strategy to improve care for ventilated patients by providing hospitals with a broader picture of their true burden of morbid complications and an objective metric to measure the impact of care-improvement initiatives. Focusing surveillance on VAC rather than only VAP will help identify more patients with potential morbidity and eliminate the inconsistencies that hindered the utility of previous definitions. Prospective studies are needed to define the best strategies to prevent ventilatorassociated events and to quantify the extent to which they are preventable. To date, very few data are available on the preventability of VAC and other ventilator-associated events.
CONCLUSIONS
The proposed definitions for VAC and other associated complications are good predictors of outcomes in children and are amenable to automated surveillance. The findings support shifting the focus of surveillance for ventilator-associated events in PICUs from only pneumonia to a broader range of complications. Further study is required to determine the methods to prevent VAC and IVAC.
